Chronic lymphocytic leukaemia trials in Norway

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  Where

  Loerenskog, Oslo, Toensberg

  Age

  18 years and over

  People

  1,200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136559 · EU 2022-501697-19-01
• Phase 3Taking people
  A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (15 cycles) venetoclax/ pirtobrutinib vs. MRD-guided venetoclax/ pirtobrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL) aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes (CLL18/ MOIRAI)

  Where

  Bergen, Loerenskog, Trondheim

  Age

  18 years and over

  People

  746 worldwide

  Run by

  University Of Cologne

  See details and how to join2023-510294-34-00 · EU 2023-510294-34-00
• Phase 1/2Taking people
  A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)

  Where

  Trondheim

  Age

  18 years and over

  People

  50 worldwide

  Run by

  Jeanette Lundin

  See details and how to joinNCT04771507